Quick Answer
REGENEREX PHARMA, INC. reported Stockholders Equity of -$4.16 million for fiscal year 2025.
REGENEREX PHARMA, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$4.16M | -2.3% |
| 2024 | -$4.06M | -261.7% |
| 2023 | -$1.12M | -13.9% |
| 2022 | -$985.6K | -18.0% |
| 2021 | -$835.0K | -73.5% |
| 2020 | -$481.3K | -30.2% |
| 2019 | -$369.7K | -15.1% |
| 2018 | -$321.1K | +0.0% |
| 2017 | -$321.1K | -15.0% |
| 2016 | -$279.1K | +64.9% |
| 2014 | -$795.4K | +53.2% |
| 2013 | -$1.70M | -126.8% |
| 2012 | -$749.7K | -512.8% |
| 2011 | -$122.3K | -889.2% |
| 2010 | $15.5K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.70M | +1.2% | -3.3% |
| June 30, 2025 | -$4.55M | -5.4% | -9.4% |
| March 31, 2025 | -$4.16M | -2.3% | +17.8% |
| December 31, 2024 | -$5.05M | -30.4% | -6.2% |
| September 30, 2024 | -$4.76M | -30.9% | -10.3% |
| June 30, 2024 | -$4.31M | -297.9% | -6.2% |
| March 31, 2024 | -$4.06M | -261.7% | -4.8% |
| December 31, 2023 | -$3.88M | -260.0% | -6.7% |
- REGENEREX PHARMA, INC. showed a decrease of -2.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, REGENEREX PHARMA, INC.’s stockholders equity has declined by 26912.5% (from $15.5 thousand to -$4.16 million).
- The most recent figure is from REGENEREX PHARMA, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: